chr1-218352886-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003238.6(TGFB2):​c.346+5839G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.228 in 152,088 control chromosomes in the GnomAD database, including 4,058 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 4058 hom., cov: 32)

Consequence

TGFB2
NM_003238.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0150

Publications

14 publications found
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
TGFB2 Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Loeys-Dietz syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.313 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003238.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
NM_003238.6
MANE Select
c.346+5839G>C
intron
N/ANP_003229.1
TGFB2
NM_001135599.4
c.346+5839G>C
intron
N/ANP_001129071.1
TGFB2
NR_138148.2
n.1712+5839G>C
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
ENST00000366930.9
TSL:1 MANE Select
c.346+5839G>C
intron
N/AENSP00000355897.4
TGFB2
ENST00000366929.4
TSL:1
c.346+5839G>C
intron
N/AENSP00000355896.4
TGFB2
ENST00000488793.1
TSL:3
n.10+5839G>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.228
AC:
34590
AN:
151970
Hom.:
4052
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.189
Gnomad AMI
AF:
0.309
Gnomad AMR
AF:
0.217
Gnomad ASJ
AF:
0.273
Gnomad EAS
AF:
0.294
Gnomad SAS
AF:
0.326
Gnomad FIN
AF:
0.286
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.228
Gnomad OTH
AF:
0.233
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.228
AC:
34620
AN:
152088
Hom.:
4058
Cov.:
32
AF XY:
0.231
AC XY:
17171
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.189
AC:
7850
AN:
41480
American (AMR)
AF:
0.217
AC:
3321
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.273
AC:
949
AN:
3470
East Asian (EAS)
AF:
0.294
AC:
1519
AN:
5168
South Asian (SAS)
AF:
0.327
AC:
1576
AN:
4824
European-Finnish (FIN)
AF:
0.286
AC:
3025
AN:
10566
Middle Eastern (MID)
AF:
0.231
AC:
68
AN:
294
European-Non Finnish (NFE)
AF:
0.228
AC:
15529
AN:
67978
Other (OTH)
AF:
0.237
AC:
501
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1399
2797
4196
5594
6993
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.226
Hom.:
490
Bravo
AF:
0.220
Asia WGS
AF:
0.303
AC:
1055
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
12
DANN
Benign
0.81
PhyloP100
0.015
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4846476; hg19: chr1-218526228; API